Nice to see your comments @Zior, I have enjoyed reading your posts in the past and felt you had been unfairly maligned due to you not always being 100% correct. Just recently we have seen the return of some sane voices, you will know who they are, and they have been most welcome. The science is the only story here, the rest is static and will be soon forgotten if that science stands up against previous treatments. Going down the route of unmet need is obviously going to be the quickest path to approval so heading in this direction would most likely attract the most attention. I genuinely hope that you continue to contribute as many here enjoyed you analysis.
DYOR opinion only
IMU Price at posting:
4.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)